Evotec company information, Employees & Contact Information

Stock Information Evotec

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France Sandoz

Evotec Shifts to Asset-Light Model as Biologics Division Outperforms Amid $300M Sandoz Deal Stock Titan

Evotec: Recovery Seems To Be Beginning (NASDAQ:EVO) Seeking Alpha

Governance Evotec

Evotec SE adjusts revenue guidance while confirming profit guidance TradingView

Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy MedCity News

Earnings call transcript: Evertec Q2 2025 earnings beat expectations Investing.com

Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec PR Newswire

Puma, Evotec, and Globex Mining: INSIDER ALERT and BUY RECOMMENDATION! | 2025-08-20 | Investing News Stockhouse

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial BioPharma Dive

Evotec's $300M Biologics Deal with Sandoz Signals Major Shift to Asset-Light Strategy Stock Titan

Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site TradingView

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions PR Newswire

Evotec: Some Recovery Has Come, But Much More Is Expected Seeking Alpha

Evotec Slashes Revenue Forecast by €80M But Strategic Shift Preserves Profit Outlook Stock Titan

Evotec SE reports H1 2025 results: Strong progress on strategy execution TradingView

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction PR Newswire

Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb Stock Titan

Halozyme withdraws $2B bid for Evotec after German biotech was 'unwilling to engage' Fierce Biotech

Sustainability (ESG) Evotec

Developing Life-Saving Oligonucleotide-Based Therapies for H-ABC Leukodystrophy Evotec

CRISPR-Cas9 in Drug Discovery Evotec

PanHunter: An Interactive Multi-omics Analysis Platform Evotec

Halozyme keeps Neutral rating, price target set on acquisition interest Investing.com

Evotec to cut 400 workers and close sites, citing ‘no new signals of recovery’ this year Endpoints News

A Piece Of The Puzzle Missing From Evotec SE's (ETR:EVT) 32% Share Price Climb simplywall.st

Evotec's latest DOD contract provides $74M to tackle mpox Fierce Biotech

Halozyme’s €2 billion bid to transform drug discovery Drug Target Review

Evotec (EVO) Stock: Weak Performance; Long-Term Potential Seeking Alpha

Evotec SE to announce first half-year results 2025 on 13 August 2025 Yahoo Finance

Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition Yahoo Finance

Evotec Strikes $300M Biologics Facility Deal with Sandoz, Secures Future Revenue Streams Stock Titan

Evotec (NASDAQ: EVO) advances preclinical BMS neuroscience programs, receives $25M Stock Titan

Sandoz acquisition to boost in-house biosimilar capabilities European Pharmaceutical Review

German drug development company says cyberattack causing production delays The Record from Recorded Future News

Speaking from experience, Evotec shares solutions to cyberattacks BioCentury

Earnings call: Evotec SE meets 2023 guidance, appoints new CEO Investing.com

J&J jumps onto Evotec’s receptor platform in drug discovery deal Fierce Biotech

Evotec adjusts revenue guidance and confirms profit guidance anticipating a more profitable revenue mix TradingView

Evotec (XTRA:EVT): Exploring the Valuation Narrative Behind Recent Investor Interest simplywall.st

Earnings call transcript: Evertec Q2 2025 shows steady growth, stock rises Investing.com

Evotec Up for Potential $4B More in Lucrative BMS Partnership BioSpace

Evotec wants to prevent the next COVID-19 crisis, and you could help Fierce Biotech

San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offer San Diego Union-Tribune

Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site ACCESS Newswire

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France Medical Dialogues

A candidate antibody drug for prevention of malaria Nature

Halozyme: Growth Amid Uncertainty After Failed Acquisition (Rating Downgrade) (HALO) Seeking Alpha

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners ACCESS Newswire

EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership Business Wire

Pharmalittle: We're reading about Trump's FDA pick, problems with a Merck asthma drug, and more statnews.com

Manufacturing Biologics in a J.POD Facility BioProcess International

Bayer, Haplogen ink R&D deal for pulmonary diseases Fierce Biotech

Novo Nordisk adds to diabetes pipeline with Evotec deal Fierce Biotech

The one that got away : the 2008 Carl F. Bucherer Patravi EvoTec en.worldtempus.com

TAKEOVER SPECULATION! Barrick Mining, Evotec, Desert Gold | 2025-07-23 | Investing News Stockhouse

P2X3 Receptor Antagonist Field Murkier as Bayer Abandons Program BioSpace

Earnings call transcript: Evertec Q2 2025 shows steady growth, stock rises Investing.com UK

Evotec (EVO) Zacks Investment Research

Tested: Evotech-Performance Hand Guard Protectors review bennetts.co.uk

Close-Up: Carl F. Bucherer Patravi EvoTec PowerReserve WatchTime